MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Making depression treatments better

Back to psychology news Blogs list Cancer blog  


Subscribe To Psychology News RSS Feed  RSS content feed What is RSS feed?

Making depression treatments better




New research clarifies how neurotransmitters like norepinephrine, serotonin, and dopamine, are regulated a finding that may help fine-tune therapies for depression.

Current drugs for depression target the regulatory process for neurotransmitters, and while effective in some cases, do not appear to work in other cases.

Recent findings suggest that synucleins, a family of small proteins in the brain, are key players in the management of neurotransmitters -- specifically, alpha- and gamma-synuclein. Additionally, scientists have found elevated levels of gamma-synuclein in the brains of both depressed animals and humans.



Making depression treatments better

In a study presented at the 39th annual meeting of the Society for Neuroscience, Georgetown University Medical Center scientists observed increased depressive-like behavior in mice where gamma-synuclein acts alone to regulate neurotransmitters, confirming earlier studies by this group.

"These findings show the importance of, and clarify a functional role for, gamma synuclein in depression and may provide new therapeutic targets in therapy of this disease," says Adam Oaks, a student researcher in the Laboratory of Molecular Neurochemistry at GUMC. "Understanding how current therapies work with the synucleins is important because the drugs don't work for all patients, and some are linked to side effects including an increased risk of suicide".


Posted by: JoAnn    Source




Did you know?
New research clarifies how neurotransmitters like norepinephrine, serotonin, and dopamine, are regulated a finding that may help fine-tune therapies for depression. Current drugs for depression target the regulatory process for neurotransmitters, and while effective in some cases, do not appear to work in other cases.

Medicineworld.org: Making depression treatments better

Acute bacterial meningitis| Alzheimer's disease| Carpal tunnel syndrome| Cerebral aneurysms| Cerebral palsy| Chronic fatigue syndrome| Cluster headache| Dementia| Epilepsy seizure disorders| Febrile seizures| Guillain barre syndrome| Head injury| Hydrocephalus| Neurology| Insomnia| Low backache| Mental retardation| Migraine headaches| Multiple sclerosis| Myasthenia gravis| Neurological manifestations of aids| Parkinsonism parkinson's disease| Personality disorders| Sleep disorders insomnia| Syncope| Trigeminal neuralgia| Vertigo|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.